Year: 2022
-
Second-year Medical Students Help Address Food Insecurity
As part of their second-year MD curriculum, a group of Feinberg students recently designed and implemented a community quality improvement project on food insecurity.
-
Glucocorticoids Enhance Muscles Through Sex-Specific Pathways
Glucocorticoid steroids improved muscle performance through distinct, sex-specific mechanisms, according to a Northwestern Medicine study.
-
Potassium Channel Dysfunction in Genetic Epilepsy
Northwestern Medicine scientists discovered functional links between dozens of potassium channel gene variants and neonatal epilepsy.
-
Proactive Machine Learning Could Speed Healthcare Innovation
Shifting machine learning workflows to a proactive model could speed data collection and analysis, according to a viewpoint published in JAMA.
-
Good Outcomes in COVID-19 Lung Transplants
Patients with COVID-19-associated lung disease who received lung transplants had similar outcomes compared to patients without COVID-19, according to a study published in JAMA.
-
Intensive Crohn’s Treatment is Safe
Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care.
-
Investigators Identify New Connections Between Circadian Rhythm and Muscle Repair
Northwestern Medicine investigators have discovered a novel mechanism that connects circadian rhythm-controlled cellular metabolism and regeneration with muscle repair after injury.
-
Optimizing Balance of Treatments in Prostate Cancer
Patients receiving radiotherapy to treat high-risk prostate cancer benefit from androgen deprivation therapy, and length of treatment may be dependent on radiation deliver, according to a recent study.
-
Genetics of Eosinophilic Colitis Revealed
A genetic analysis indicates eosinophilic colitis is distinct from other eosinophilic gastrointestinal diseases and inflammatory bowel disease, according to a recent study.
-
New Treatment for Metastatic Hormone-Sensitive Prostate Cancer
The drug darolutamid, administered with standard androgen-deprivation therapy and docetaxel chemotherapy, increased survival in patients with metastatic hormone-sensitive prostate cancer.
